These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31971066)

  • 1. Recovery of cognitive function after relapse in multiple sclerosis.
    Benedict RH; Pol J; Yasin F; Hojnacki D; Kolb C; Eckert S; Tacca B; Drake A; Wojcik C; Morrow SA; Jakimovski D; Fuchs TA; Dwyer MG; Zivadinov R; Weinstock-Guttman B
    Mult Scler; 2021 Jan; 27(1):71-78. PubMed ID: 31971066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing cognitive function during relapse in multiple sclerosis.
    Benedict RH; Morrow S; Rodgers J; Hojnacki D; Bucello MA; Zivadinov R; Weinstock-Guttman B
    Mult Scler; 2014 Nov; 20(13):1745-52. PubMed ID: 24842959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.
    Morrow SA; Conway D; Fuchs T; Wojcik C; Unverdi M; Yasin F; Pol J; Eckert S; Hojnacki DH; Dwyer M; Zivadinov R; Weinstock-Guttman B; Benedict RH
    Mult Scler; 2021 Jun; 27(7):1077-1087. PubMed ID: 33259273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
    Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
    Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results.
    Wilken J; Traboulsee A; Nelson F; Ionete C; Kolind S; Fratto T; Kane R; Gandhi R; Rawlings AM; Roesch N; Ozog MA; DeLuca J;
    Mult Scler Relat Disord; 2023 May; 73():104677. PubMed ID: 37028124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting isolated cognitive relapses in persons with MS.
    Morrow SA; Weinstock ZL; Mirmosayyeb O; Conway D; Fuchs T; Jaworski MG; Eckert S; Hojnacki DH; Dwyer MG; Zivadinov R; Weinstock-Guttman B; Benedict RHB
    Mult Scler; 2023 Dec; 29(14):1786-1794. PubMed ID: 37776097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset.
    Castrogiovanni N; Mostert J; Repovic P; Bowen JD; Uitdehaag BMJ; Strijbis EMM; Cutter GR; Koch MW
    Neurology; 2023 Jul; 101(1):e1-e11. PubMed ID: 37072219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
    Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
    Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of the Symbol Digit Modalities Test in a revised assessment of 'no evidence of disease activity-4 (NEDA-4)' in Latin-American patients with multiple sclerosis.
    Guevara C; Villa E; Diaz V; Garrido C; Martinez M; Orellana P; Alarcón P; Silva-Rosas C; Barker GJ; Kempton MJ; de Grazia J
    Mult Scler Relat Disord; 2020 Jul; 42():102076. PubMed ID: 32361478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute relapses on neuropsychological status in multiple sclerosis patients.
    Morrow SA; Jurgensen S; Forrestal F; Munchauer FE; Benedict RH
    J Neurol; 2011 Sep; 258(9):1603-8. PubMed ID: 21384163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.